Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California

Public research footprint of Palo Alto Medical Foundation-Santa Cruz, compiled from the ClinicalTrials.gov public registry.

136

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Platinum-Resistant Ovarian Carcinoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma · Stage IIIB Lung Cancer AJCC v8

Recently updated registry entries

NCT03419234 — Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone… (Active Not Recruiting)
NCT02311933 — Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced… (Active Not Recruiting)
NCT06058377 — Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Palo Alto Medical Foundation-Santa Cruz?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.